U.S. federal trademark · Serial No. 86601234 · Reg. No. 4859041
Medicinal preparations for the treatment of infectious diseases and for use in oncology, namely, intravenously administered injectable therapeutic delivery agents comprising polymeric nano-particles incorporating therapeutic payloads, which accumulate at the site of diseased and cancerous cells to specifically target these cells for controlled and timely release of the therapeutic payload
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.